Endothelin-I: A multifunctional molecule in cancer

British Journal of Cancer

Volumn 88, Issue 2, 2003, Pages 163-166

  Grant, K ^a   Loizidou, M ^a   Taylor, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Angiogenesis; Apoptosis; Cancer; Endothelin I; Tumour growth

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; G PROTEIN COUPLED RECEPTOR; METALLOPROTEINASE; MITOGENIC AGENT; ENDOTHELIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; CANCER; CANCER INVASION; CARCINOGENESIS; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; HEART FAILURE; HYPERTENSION; METASTASIS; MITOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SHORT SURVEY; SWINE; VASCULAR TISSUE; DISEASE COURSE; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

APOPTOSIS; DISEASE PROGRESSION; ENDOTHELIN-1; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ENDOTHELIN;

EID: 0037467569     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6700750     Document Type: Short Survey

References (40)

1. Alanen K, Deng DX, Chakrabarti S (2000) Augmented expression of endothelin-1, endothelin-3 and the endothelin B receptor in breast cancer. Histopathology 36: 161-167
2. Ali H, Dashwood M, Dawas K, Loizidou M, Savage F, Taylor I (2000a) Endothelin receptor expression in colorectal cancer. J Cardiovasc Pharm 36: S69-S71
3. Ali H, Loizidou M, Dashwood M, Savage F, Sheard C, Taylor I (2000b) Stimulation of colorectal cancer cell line growth by ET-1 and its inhibition by ET(A) antagonists. Gut 47: 685-688
4. Asham EH, Shankar A, Loizidou M, Fredericks S, Miller K, Boulos PB, Burnstock G, Taylor I (2001) Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ETA receptor antagonism. Br J Cancer 85: 1759-1763, doi: 10.1054/bjoc.2001.2193
5. Bagnato A, Tecce R, Moretti C, DiCastro V, Spergel D, Catt KG (1995) Autocrine actions of ET-1 as a growth factor in human ovarian carcinoma cells. Clin Cancer Res 1: 1059-1066
6. Bagnato A, Salani D, Di CV, Wu-Wong JR, Tecce R, Nicotra MR, Venuti A, Natali PG (1999) Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumour growth. Cancer Res 59: 720-727
7. Bagnato A, Salani D, Di CV, Wu-Wong JR, Tecce R, Nicotra MR, Venuti A, Natali PG (1999) Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumour growth. Cancer Res 59: 720-727
8. Bek E, McMillen M (2000) Endothelins are angiogenic. J Cardiovasc Pharmacol 36: S135-S139
9. Carducci M, Nelson JB, Bowling K, Rogers T, Eisenberger MA, Sinibaldi V, Donehower R, Leahy TL, Carr RA, Isaacson JD, Janus TJ, Andre A, Hosmane BS, Padley RJ (2002) Atrasentan, and endothelin-receptor antagonist for refractory andenocarcinomas: safety and pharmacokinetics. J Clin Oncol 20: 2171-2180, doi: 10.1200/JCO.2002.08.028
10. Chiao W, Moonga BS, Yang Y, Kancherla R, Mittelman A, Wu-Wong JR, Ahmed T (2000) Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone reabsorption. Br J Cancer 83: 360-365
11. Egidy G, Juillerat-Jeanneret L, Jeannin J, Korth P, Bosman F, Pinet F (2000) Modulation of human colon tumour - stromal interactions by the endothelial system. Am J Pathol 157: 1863-1874
12. Ferrari-Bravo A, Franciosi C, Lissoni P, Fumagalli L, Uggeri F (2000) Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancer. Int J Biomarkers 15: 56-57
13. Gohji K, Tamada H, Katsuoka Y, Nakajima M (2001) Expression of endothelin receptor A associated with prostate cancer progression. J Urol 165: 1033-1036
14. Kernochan LE, Tran BN, Tangkijvanich P, Melton AC, Tam SP, Lee HF (2002) Endothelin-1 stimulates human colonic myofibroblast contraction and migration. Gut 50: 65-70
15. Kikuchi K, Nakagawa H, Kaduno T, Etoh T, Byers HR, Mihm MC, Tamaki K (1996) Decreased ETB receptor expression in human metastatic melanoma cells. Biochem Biophys Res Comm 219: 734-739
16. Komuro I, Kurihara H, Yoshizumi M, Takaku F, Yazaki Y (1988) Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249-252
17. Kusuhara M, Yamaguchi K, Nagasaki K, Hayashi C, Hori S, Handa S, Nakamura Y, Abe K (1990) Production of endothelin in human cancer cell lines. Cancer Res 50: 3257-3261
18. Lahav R, Heffner G, Pattersen PH (1999) An endothelin receptor B antagonist inhibits growth and induces cell death in vitro and in vivo. Proc Natl Acad Sci USA 96: 11496-11500
19. Matsuura A, Yamochi W, Hirata K, Kawashima S, Yokoamam M (1998) Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. Hypertension 32: 89-95
20. Moraitis S, Miller WR, Smyth JF, Langdon SP (1999) Paracrine regulation of ovarian cancer by endothelin. Eur J Cancer 35: 1381-1387
21. Nakamuta M, Ohashi M, Tabata S, Tanabe Y, Goto K, Narise M, Narise K, Hiroshige K, Nowata H (1993) Raised plasma concentration of endothelin-like inmmunoreactivity in patients with hepatocellular carcinoma. Am J Pathol 88: 248-252
22. Nelson JB, Chan-Tack K, Hedican SP, Magnuson S, Opgenorth TJ, Bora G (1996) Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56: 663-668
23. Nelson JB, Hedican SP, George DJ, Reddi AH, Piantasposi S, Eisenberger MA, Simons JW (1995) Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1: 994-999
24. Nelson JB, Nguyen SH, Wu-Wong JR, Opgenorth TJ, Dixon BD, Chung LW, Inoue N (1999) New bone formation in an osteoblastic tumour model is increased by endothelin-1 overexpression and decreased by ETA receptor blockade. Urology 53: 1063-1069
25. Pao M, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones P (2001) The endothelin receptor B (EDNRB) promotor displays heterogeneous, site specific methylation patterns in normal and tumour cells. Hum Mol Genet 10: 903-910.
26. Pedram A, Razandi M, Hu RM, Levin E (1997) Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 272: 17097-17103
27. Peduto-Eberl L, Valdenaire O, Saintgiorgio V, Jeannin J, Juillerat-Jeanneret L (2000) Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells. Int J Cancer 86: 182-187
28. Rosano L, Varmi M, Salani D, Di CV, Spinella F, Natali PG, Bagnato A (2001) Endothelin-1 induces tumour proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 61: 8340-8346
29. Sakamoto A, Yanagisawa M, Takuwa Y, Masaki T (1991) Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophy Res Comm 178: 656-663
30. Salani D, Di CV, Nicotra MR, Rosano L, Tecce R, Venuti A, Natali PG, Bagnato A (2000a) Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 157: 1537-1547
31. Salani D, Taraboletti G, Rosano L, Di CV, Borsotti P, Giavazzi R, Bagnato A (2000b) Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157: 1703-1711
32. Shankar A, Loizidou M, Aliev G, Fredericks S, Holt D, Boulos PB, Burnstock G, Taylor I (1998) Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg 85: 502-506
33. Shichiri M, Kato H, Marumo F, Hirata Y (1997) Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 30: 1198-1203
34. Simpson RA, Dickinson T, Porter KE, London NJM, Hemingway DM (2000) Raised levels of plasma big endothelin-1 in patients with colorectal cancer. Br J Surg 87: 1409-1413
35. Suzuki T, Watanabe K, Kasukawa R, Suzuki T (1998) Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma. Fukushima J Med Sci 44: 93-105
36. Wu-Wong JR, Chiou WJ, Dickinson T, Opgenorth TJ (1997) Endothelin attenuates apoptosis in human smooth muscle cells. Biochemical Journal 328: 733-737
37. Yamashita J, Ogawa M, Inada K, Yamashita S, Matsuo S, Takano S (1991) A large amount of endothelin-1 is present in human breast cancer tissues. Res Comm Chem Path Pharmacol 74: 363-369
38. Yang Z, Krasnici N, Luscher TF (1999) Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade. Circulation 100: 5-8
39. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415
40. Yohn JJ, Smith C, Stevens T, Hoffman TA, Morelll JG, Hurt DL, Yanagisawa M, Kane MA, Zamora MR (1994) Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Comm 201: 449-457.